Area of research
Oncology · Geriatrics and Gerontology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Frailty in Older Adults, COVID-19 and healthcare impacts, and COVID-19 Clinical Research Studies.
Geriatric Oncology: A 5-Year Strategic Plan
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Immunotherapy comes of age: Immune aging & checkpoint inhibitors
Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults
Immune Checkpoint Inhibitors in Older Adults